Skip Navigation



Radiation Protection Dosimetry Advance Access published online on February 3, 2006
Radiation Protection Dosimetry, doi:10.1093/rpd/nci766
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/1-3/330    most recent
nci766v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Faulkner, K.
Right arrow Articles by Law, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faulkner, K.
Right arrow Articles by Law, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Leuvens Special Issue Article

MAMMOGRAPHIC BREAST CANCER SCREENING FOR WOMEN PREVIOUSLY TREATED WITH HIGH BREAST DOSES FOR DISEASES SUCH AS HODGKIN'S

K. Faulkner 1 * and J. Law 2

1 Quality Assurance Reference Centre, Unit 9, Kingfisher Way, Silverlink Business Park, Wallsend, Tyne and Wear NE28 9ND, UK
2 Medical Physics, The Chancellor's Building, 49 Little France Crescent, Edinburgh EH16 4SB, UK

* To whom correspondence should be addressed.
K. Faulkner, E-mail: keith.faulkner{at}nhs.net


  Abstract

In screening of a general population for breast cancer, benefit/risk ratios are of the order of 100/1. For the very small subgroup of women treated by radiotherapy for Hodgkin's disease below age 35, calculations of this type require different considerations, an overview of which is given in this text. It is concluded that although such previous exposures will increase their radiation risk, their increased risk of carrying an undetected breast cancer means that the potential benefit for them of screening is increased even more. In the United Kingdom, the Department of Health has recommended annual screening for these women.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Radiat Prot DosimetryHome page
K. Faulkner
The DIMOND project and its impact on radiation protection
Radiat Prot Dosimetry, December 1, 2005; 117(1-3): 3 - 6.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.